Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on July 8, 2026

Jul. 8, 2026

VALLOUREC CONFIRMS ITS INTENTION TO RETURN CLOSE TO €650 MILLION TO SHAREHOLDERS IN 2026 FOLLOWING THE COMPLETION OF ITS SHARE BUYBACK PROGRAM AND THE FULL EXERCISE OF THE WARRANTS

Indeterminate GlobeNewswire

Jul. 8, 2026

VALLOUREC CONFIRME SON INTENTION DE DISTRIBUER PRES DE 650 MILLIONS D’EUROS A SES ACTIONNAIRES EN 2026 APRES LA FINALISATION DE SON PROGRAMME DE RACHAT D’ACTIONS ET L’EXERCICE INTEGRAL DES BONS DE SOUSCRIPTION D’ACHAT

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical Mengadakan Perjanjian dengan Novo Nordisk untuk Mengevaluasi NPM-139, Implan Semaglutide Miniatur dengan Kerja Sangat Panjang untuk Pengelolaan Berat Badan Kronis

Indeterminate GlobeNewswire

Jul. 8, 2026

ヴィヴァニ・メディカル、慢性体重管理のためのセマグルチドの超長時間作用小型インプラント「NPM-139」の評価に向け、ノボ ノルディスクと契約を締結

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical, 만성 체중관리용 초장기 지속형 세마글루타이드 임플란트 'NPM-139' 평가 위해 Novo Nordisk와 계약 체결

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical Menandatangani Perjanjian dengan Novo Nordisk bagi Menilai NPM-139, Implan Semaglutide Miniatur dengan Tindakan Ultra Jangka Panjang bagi Pengurusan Berat Badan Kronik

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical เข้าทำข้อตกลงกับ Novo Nordisk เพื่อประเมิน NPM-139…

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical 与 Novo Nordisk 达成协议，评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139

Indeterminate GlobeNewswire

Jul. 8, 2026

Vivani Medical 與 Novo Nordisk 達成協議，評估一種微型、超長效並用於慢性體重管理的司美格魯肽植入劑 NPM-139

Indeterminate GlobeNewswire

Jul. 8, 2026

Acronis Research and Development Wins Workforce Transformation Award at SGTech Industry Gala 2026

Indeterminate GlobeNewswire

Jul. 8, 2026

Crypto News Today: AlphaPepe Presale Nears $2M Raised as Bitcoin Price Prediction Eyes New All-Time Highs

Indeterminate GlobeNewswire

Jul. 8, 2026

As AI Moves Into the Physical World, Humanity & AGI Summit 2026 Brings Global Leaders to Stanford

Indeterminate GlobeNewswire